Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Hydreight Technologies Inc ( (TSE:NURS) ) has shared an update.
Hydreight Technologies Inc. has successfully closed an oversubscribed $11.5 million convertible debenture offering, including the full exercise of an over-allotment option. This funding will support the company’s growth strategy and long-term goals, as it has recently achieved profitability. The offering was led by Canaccord Genuity Corp. and involved a syndicate of agents. The proceeds are intended for general corporate and working capital purposes, with the offering subject to final approval by the TSX Venture Exchange.
The most recent analyst rating on (TSE:NURS) stock is a Buy with a C$8.50 price target. To see the full list of analyst forecasts on Hydreight Technologies Inc stock, see the TSE:NURS Stock Forecast page.
More about Hydreight Technologies Inc
Hydreight Technologies Inc. is a leader in digital healthcare solutions, focusing on building one of the largest mobile clinic networks in the United States. The company offers a proprietary, fully integrated platform to support its services.
Average Trading Volume: 344,259
Technical Sentiment Signal: Buy
Current Market Cap: C$87.82M
Find detailed analytics on NURS stock on TipRanks’ Stock Analysis page.